Q7KZI7 (MARK2_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 105.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Serine/threonine-protein kinase MARK2 EC=2.7.11.1 EC=2.7.11.26 Alternative name(s): ELKL motif kinase 1 Short name=EMK-1 MAP/microtubule affinity-regulating kinase 2 PAR1 homolog PAR1 homolog b Short name=Par-1b Short name=Par1b | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 788 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Serine/threonine-protein kinase involved in cell polarity and microtubule dynamics regulation. Phosphorylates CRTC2/TORC2, DCX, HDAC7, KIF13B, MAP2, MAP4, MAPT/TAU, and RAB11FIP2. Plays a key role in cell polarity by phosphorylating the microtubule-associated proteins MAP2, MAP4 and MAPT/TAU at KXGS motifs, causing detachment from microtubules, and their disassembly. Regulates epithelial cell polarity by phosphorylating RAB11FIP2. Involved in the regulation of neuronal migration through its dual activities in regulating cellular polarity and microtubule dynamics, possibly by phosphorylating and regulating DCX. Regulates axogenesis by phosphorylating KIF13B, promoting interaction between KIF13B and 14-3-3 and inhibiting microtubule-dependent accumulation of KIF13B. Also required for neurite outgrowth and establishment of neuronal polarity. Regulates localization and activity of some histone deacetylases by mediating phosphorylation of HDAC7, promoting subsequent interaction between HDAC7 and 14-3-3 and export from the nucleus. Also acts as a positive regulator of the Wnt signaling pathway, probably by mediating phosphorylation of dishevelled proteins (DVL1, DVL2 and/or DVL3). Modulates the developmental decision to build a columnar versus a hepatic epithelial cell apparently by promoting a switch from a direct to a transcytotic mode of apical protein delivery. Essential for the asymmetric development of membrane domains of polarized epithelial cells. Ref.6 Ref.8 Ref.9 Ref.10 Ref.11 Ref.13 Ref.15 Ref.16 Ref.22 Ref.26 |
| Catalytic activity | ATP + a protein = ADP + a phosphoprotein. Ref.10 ATP + [tau protein] = ADP + [tau protein] phosphate. |
| Cofactor | Magnesium By similarity. Ref.10 |
| Enzyme regulation | Inhibited by PAK7/PAK5; inhibition is independent of the kinase activity of PAK7/PAK5 By similarity. Activated by phosphorylation on Thr-208. Inhibited by phosphorylation at Ser-212 and Thr-596. Inhibited by hymenialdisine. Specifically inhibited by the H.pylori CagA peptide FPLKRHDKVDDLSK that mimics host substrates and binds to the kinase substrate-binding site. Ref.8 Ref.10 |
| Subunit structure | Homodimer. Interacts with PAK7/PAK5; leading to inhibit the protein kinase activity By similarity. Interacts (when phosphorylated at Thr-596) with YWHAZ. In case of infection, interacts with H.pylori CagA, leading to inhibit kinase activity and junctional and polarity defects. Ref.13 Ref.18 |
| Subcellular location | Cell membrane; Peripheral membrane protein. Cytoplasm. Note: Phosphorylation at Thr-596 by PRKCZ/aPKC and subsequent interaction with 14-3-3 protein YWHAZ promotes relocation from the cell membrane to the cytoplasm. Ref.12 Ref.13 |
| Tissue specificity | High levels of expression in heart, brain, skeletal muscle and pancreas, lower levels observed in lung, liver and kidney. Ref.1 |
| Domain | The UBA domain does not seem to bind ubiquitin and ubiquitin-like and might play a role in regulating the enzyme conformation and localization. Activation of the kinase activity following phosphorylation at Thr-208 is accompanied by a conformational change that alters the orientation of the UBA domain with respect to the catalytic domain. Ref.23 The KA1 domain mediates binding to phospholipids and targeting to membranes By similarity. Ref.23 |
| Post-translational modification | Autophosphorylated. Phosphorylated at Thr-208 by STK11/LKB1 in complex with STE20-related adapter-alpha (STRADA) pseudo kinase and CAB39. Phosphorylation at Thr-208 by TAOK1 activates the kinase activity, leading to phosphorylation and detachment of MAPT/TAU from microtubules. Phosphorylation at Ser-212 by GSK3-beta (GSK3B) inhibits the kinase activity. Phosphorylation by CaMK1 promotes activity and is required to promote neurite outgrowth. Phosphorylation at Thr-596 by PRKCZ/aPKC in polarized epithelial cells inhibits the kinase activity and promotes binding to 14-3-3 protein YWHAZ, leading to relocation from cell membrane to cytoplasm. Ref.10 Ref.12 Ref.13 |
| Sequence similarities | Belongs to the protein kinase superfamily. CAMK Ser/Thr protein kinase family. SNF1 subfamily. Contains 1 KA1 (kinase-associated) domain. Contains 1 protein kinase domain. Contains 1 UBA domain. |
| Sequence caution | The sequence AAK82368.1 differs from that shown. Reason: Erroneous initiation. Translation N-terminally extended. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| PARD6G | Q9BYG4 | 2 | EBI-516560,EBI-295417 | |
| YWHAB | P31946 | 2 | EBI-516560,EBI-359815 | |
| YWHAG | P61981 | 2 | EBI-516560,EBI-359832 | |
| YWHAH | Q04917 | 6 | EBI-516560,EBI-306940 | |
| YWHAZ | P63104 | 3 | EBI-516560,EBI-347088 |
Alternative products
| This entry describes 16 isoforms produced by alternative promoter usage and alternative splicing. [Align] [Select] | ||||||
| Isoform 1 Ref.3 (identifier: Q7KZI7-1) Also known as: Alpha; This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Note: Produced by alternative promoter usage. No experimental confirmation available. | ||||||
| Isoform 2 Ref.1 (identifier: Q7KZI7-2) The sequence of this isoform differs from the canonical sequence as follows: 1-33: Missing. 505-558: Missing. | ||||||
| Note: Produced by alternative splicing of isoform 6. | ||||||
| Isoform 3 Ref.1 (identifier: Q7KZI7-3) The sequence of this isoform differs from the canonical sequence as follows: 1-33: Missing. 644-652: Missing. | ||||||
| Note: Produced by alternative splicing of isoform 6. | ||||||
| Isoform 4 Ref.6 (identifier: Q7KZI7-4) Also known as: Par-1Balpha; The sequence of this isoform differs from the canonical sequence as follows: 505-558: Missing. 644-652: Missing. | ||||||
| Note: Produced by alternative splicing of isoform 1. | ||||||
| Isoform 5 Ref.3 (identifier: Q7KZI7-5) The sequence of this isoform differs from the canonical sequence as follows: 505-558: Missing. 654-668: Missing. | ||||||
| Note: Produced by alternative splicing of isoform 1. | ||||||
| Isoform 6 Ref.3 (identifier: Q7KZI7-6) Also known as: Beta; The sequence of this isoform differs from the canonical sequence as follows: 1-33: Missing. | ||||||
| Note: Produced by alternative promoter usage. No experimental confirmation available. | ||||||
| Isoform 7 Ref.3 (identifier: Q7KZI7-7) The sequence of this isoform differs from the canonical sequence as follows: 1-33: Missing. 505-558: Missing. 644-652: Missing. | ||||||
| Note: Produced by alternative splicing of isoform 6. No experimental confirmation available. | ||||||
| Isoform 8 Ref.3 (identifier: Q7KZI7-8) The sequence of this isoform differs from the canonical sequence as follows: 644-652: Missing. | ||||||
| Note: Produced by alternative splicing of isoform 1. No experimental confirmation available. | ||||||
| Isoform 9 Ref.3 (identifier: Q7KZI7-9) The sequence of this isoform differs from the canonical sequence as follows: 505-558: Missing. | ||||||
| Note: Produced by alternative splicing of isoform 1. No experimental confirmation available. | ||||||
| Isoform 10 Ref.3 (identifier: Q7KZI7-10) The sequence of this isoform differs from the canonical sequence as follows: 1-33: Missing. 505-558: Missing. 654-668: Missing. | ||||||
| Note: Produced by alternative splicing of isoform 6. No experimental confirmation available. | ||||||
| Isoform 11 Ref.3 (identifier: Q7KZI7-11) The sequence of this isoform differs from the canonical sequence as follows: 654-668: Missing. | ||||||
| Note: Produced by alternative splicing of isoform 1. No experimental confirmation available. | ||||||
| Isoform 12 Ref.3 (identifier: Q7KZI7-12) The sequence of this isoform differs from the canonical sequence as follows: 1-33: Missing. 654-668: Missing. | ||||||
| Note: Produced by alternative splicing of isoform 6. No experimental confirmation available. | ||||||
| Isoform 13 (identifier: Q7KZI7-13) The sequence of this isoform differs from the canonical sequence as follows: 1-33: Missing. 412-412: Missing. 505-558: Missing. 644-652: Missing. | ||||||
| Note: Produced by alternative splicing of isoform 6. Contains a phosphoserine at position 376. | ||||||
| Isoform 14 (identifier: Q7KZI7-14) The sequence of this isoform differs from the canonical sequence as follows: 1-33: Missing. 412-412: Missing. 644-652: Missing. | ||||||
| Note: Produced by alternative splicing of isoform 6. Contains a phosphoserine at position 376. | ||||||
| Isoform 15 (identifier: Q7KZI7-15) The sequence of this isoform differs from the canonical sequence as follows: 412-412: Missing. 505-558: Missing. 645-668: Missing. | ||||||
| Note: Produced by alternative splicing of isoform 1. Contains a phosphoserine at position 409. | ||||||
| Isoform 16 (identifier: Q7KZI7-16) The sequence of this isoform differs from the canonical sequence as follows: 412-412: Missing. 505-558: Missing. 644-652: Missing. | ||||||
| Note: Produced by alternative splicing of isoform 1. Contains a phosphoserine at position 409. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 788 | 788 | Serine/threonine-protein kinase MARK2 | PRO_0000086301 | |||||||||||||||||||||||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Domain | 53 – 304 | 252 | Protein kinase | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Domain | 323 – 362 | 40 | UBA | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Domain | 739 – 788 | 50 | KA1 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Nucleotide binding | 59 – 67 | 9 | ATP By similarity UniProtKB Q9H0K1 | ||||||||||||||||||||||||||||||||||||||||||||||||||
Sites | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Active site | 175 | 1 | Proton acceptor By similarity UniProtKB Q9H0K1 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Binding site | 82 | 1 | ATP By similarity UniProtKB O08678 | ||||||||||||||||||||||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 40 | 1 | Phosphoserine Ref.31 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 58 | 1 | Phosphothreonine; by autocatalysis By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 91 | 1 | Phosphoserine; by CaMK1 By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 92 | 1 | Phosphoserine; by CaMK1 By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 93 | 1 | Phosphoserine; by CaMK1 By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 208 | 1 | Phosphothreonine; by LKB1 and TAOK1 Ref.10 Ref.25 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 212 | 1 | Phosphoserine; by GSK3-beta By similarity UniProtKB O08678 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 274 | 1 | Phosphoserine; by autocatalysis By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 275 | 1 | Phosphothreonine; by autocatalysis By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 294 | 1 | Phosphothreonine; by CaMK1 By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 409 | 1 | Phosphoserine Ref.21 Ref.24 Ref.25 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 456 | 1 | Phosphoserine Ref.17 Ref.19 Ref.20 Ref.21 Ref.25 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 486 | 1 | Phosphoserine Ref.14 Ref.19 Ref.21 Ref.25 Ref.31 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 493 | 1 | Phosphoserine Ref.21 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 569 | 1 | Phosphoserine Ref.24 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 571 | 1 | Phosphoserine By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 595 | 1 | Phosphoserine By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 596 | 1 | Phosphothreonine; by PKC/PRKCZ Ref.12 Ref.13 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 619 | 1 | Phosphoserine Ref.31 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 722 | 1 | Phosphoserine Ref.25 | ||||||||||||||||||||||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 1 – 33 | 33 | Missing in isoform 2, isoform 3, isoform 6, isoform 7, isoform 10, isoform 12, isoform 13 and isoform 14. Ref.1 Ref.3 | VSP_051705 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 412 | 1 | Missing in isoform 13, isoform 14, isoform 15 and isoform 16. | VSP_039872 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 505 – 558 | 54 | Missing in isoform 2, isoform 4, isoform 5, isoform 7, isoform 9, isoform 10, isoform 13, isoform 15 and isoform 16. Ref.1 Ref.3 Ref.6 | VSP_051706 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 644 – 652 | 9 | Missing in isoform 3, isoform 4, isoform 7, isoform 8, isoform 13, isoform 14 and isoform 16. Ref.1 Ref.3 Ref.6 | VSP_051707 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 645 – 668 | 24 | Missing in isoform 15. | VSP_041853 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 654 – 668 | 15 | Missing in isoform 5, isoform 11, isoform 10 and isoform 12. Ref.1 Ref.3 Ref.6 | VSP_051708 | |||||||||||||||||||||||||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 208 | 1 | T → A: Prevents phosphorylation and activation by STK11/LKB1 complex. Ref.10 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 596 | 1 | T → A: Loss of membrane dissociation and binding to YWHAZ. Ref.12 Ref.13 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 192 | 1 | A → G in CAA80914. Ref.7 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 236 | 1 | L → C in CAA80914. Ref.7 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 389 – 390 | 2 | PS → QF in CAA66229. Ref.1 | ||||||||||||||||||||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 53 – 60 | 8 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 66 – 72 | 7 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 73 – 75 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 78 – 86 | 9 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 91 – 106 | 16 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 115 – 120 | 6 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 122 – 129 | 8 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 137 – 144 | 8 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 149 – 168 | 20 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 178 – 180 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 181 – 183 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 189 – 191 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 213 – 215 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 218 – 221 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 228 – 245 | 18 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 255 – 264 | 10 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 275 – 284 | 10 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 289 – 291 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 295 – 299 | 5 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 302 – 305 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 326 – 334 | 9 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 339 – 347 | 9 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 353 – 361 | 9 | |||||||||||||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Human serine/threonine protein kinase EMK1: genome structure and cDNA cloning of isoforms produced by alternative splicing." Espinosa L., Navarro E. Cytogenet. Cell Genet. 81:278-282(1998) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 3), TISSUE SPECIFICITY. Tissue: Colon. |
| [2] | Sugiyama A., Inoue H., Oka M. Submitted (AUG-2004) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5). Tissue: Kidney. |
| [3] | "Cloning of human full-length CDSs in BD Creator(TM) system donor vector." Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S., Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y., Phelan M., Farmer A. Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 6). |
| [4] | "Human chromosome 11 DNA sequence and analysis including novel gene identification." Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K., Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F., Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G. Sakaki Y.Nature 440:497-500(2006) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4), NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 11-755 (ISOFORM 1). Tissue: Kidney and Placenta. |
| [6] | "PAR-1 is a Dishevelled-associated kinase and a positive regulator of Wnt signalling." Sun T.-Q., Lu B., Feng J.-J., Reinhard C., Jan Y.N., Fantl W.J., Williams L.T. Nat. Cell Biol. 3:628-636(2001) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 28-788 (ISOFORM 4), FUNCTION. |
| [7] | "Identification of 21 novel human protein kinases, including 3 members of a family related to the cell cycle regulator nimA of Aspergillus nidulans." Schultz S.J., Nigg E.A. Cell Growth Differ. 4:821-830(1993) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 190-237. |
| [8] | "Protein kinase MARK/PAR-1 is required for neurite outgrowth and establishment of neuronal polarity." Biernat J., Wu Y.Z., Timm T., Zheng-Fischhofer Q., Mandelkow E., Meijer L., Mandelkow E.M. Mol. Biol. Cell 13:4013-4028(2002) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, ENZYME REGULATION. |
| [9] | "Splicing alterations in human renal allografts: detection of a new splice variant of protein kinase Par1/Emk1 whose expression is associated with an increase of inflammation in protocol biopsies of transplanted patients." Hueso M., Beltran V., Moreso F., Ciriero E., Fulladosa X., Grinyo J.M., Seron D., Navarro E. Biochim. Biophys. Acta 1689:58-65(2004) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, ALTERNATIVE PROMOTER USAGE. |
| [10] | "LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1." Lizcano J.M., Goeransson O., Toth R., Deak M., Morrice N.A., Boudeau J., Hawley S.A., Udd L., Maekelae T.P., Hardie D.G., Alessi D.R. EMBO J. 23:833-843(2004) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, ENZYME REGULATION, PHOSPHORYLATION AT THR-208, MUTAGENESIS OF THR-208. |
| [11] | "Par-1 promotes a hepatic mode of apical protein trafficking in MDCK cells." Cohen D., Rodriguez-Boulan E., Musch A. Proc. Natl. Acad. Sci. U.S.A. 101:13792-13797(2004) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [12] | "Atypical PKC phosphorylates PAR-1 kinases to regulate localization and activity." Hurov J.B., Watkins J.L., Piwnica-Worms H. Curr. Biol. 14:736-741(2004) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION AT THR-596, MUTAGENESIS OF THR-596, SUBCELLULAR LOCATION. |
| [13] | "aPKC acts upstream of PAR-1b in both the establishment and maintenance of mammalian epithelial polarity." Suzuki A., Hirata M., Kamimura K., Maniwa R., Yamanaka T., Mizuno K., Kishikawa M., Hirose H., Amano Y., Izumi N., Miwa Y., Ohno S. Curr. Biol. 14:1425-1435(2004) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, SUBCELLULAR LOCATION, PHOSPHORYLATION AT THR-596, MUTAGENESIS OF THR-596, INTERACTION WITH YWHAZ. |
| [14] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-486, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [15] | "MARK2/EMK1/Par-1Balpha phosphorylation of Rab11-family interacting protein 2 is necessary for the timely establishment of polarity in Madin-Darby canine kidney cells." Ducharme N.A., Hales C.M., Lapierre L.A., Ham A.J., Oztan A., Apodaca G., Goldenring J.R. Mol. Biol. Cell 17:3625-3637(2006) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION IN PHOSPHORYLATION OF RAB11FIP2. |
| [16] | "New role for hPar-1 kinases EMK and C-TAK1 in regulating localization and activity of class IIa histone deacetylases." Dequiedt F., Martin M., Von Blume J., Vertommen D., Lecomte E., Mari N., Heinen M.F., Bachmann M., Twizere J.C., Huang M.C., Rider M.H., Piwnica-Worms H., Seufferlein T., Kettmann R. Mol. Cell. Biol. 26:7086-7102(2006) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION IN PHOSPHORYLATION OF HDAC7. |
| [17] | "A probability-based approach for high-throughput protein phosphorylation analysis and site localization." Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P. Nat. Biotechnol. 24:1285-1292(2006) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-456, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [18] | "Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity." Saadat I., Higashi H., Obuse C., Umeda M., Murata-Kamiya N., Saito Y., Lu H., Ohnishi N., Azuma T., Suzuki A., Ohno S., Hatakeyama M. Nature 447:330-333(2007) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH H.PYLORI CAGA. |
| [19] | "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis." Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III J. Proteome Res. 7:1346-1351(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-456 AND SER-486, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [20] | "Phosphoproteome of resting human platelets." Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J., Schuetz C., Walter U., Gambaryan S., Sickmann A. J. Proteome Res. 7:526-534(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-456, MASS SPECTROMETRY. Tissue: Platelet. |
| [21] | "Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle." Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., Greff Z., Keri G., Stemmann O., Mann M. Mol. Cell 31:438-448(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-409; SER-456; SER-486 AND SER-493, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [22] | "Glucose controls CREB activity in islet cells via regulated phosphorylation of TORC2." Jansson D., Ng A.C., Fu A., Depatie C., Al Azzabi M., Screaton R.A. Proc. Natl. Acad. Sci. U.S.A. 105:10161-10166(2008) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION IN PHOSPHORYLATION OF CRTC2. |
| [23] | "The ubiquitin-associated domain of AMPK-related kinases regulates conformation and LKB1-mediated phosphorylation and activation." Jaleel M., Villa F., Deak M., Toth R., Prescott A.R., Van Aalten D.M., Alessi D.R. Biochem. J. 394:545-555(2006) [PubMed] [Europe PMC] [Abstract] Cited for: DOMAIN UBA. |
| [24] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-569, PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-376 (ISOFORMS 13 AND 14), PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-409 (ISOFORMS 15 AND 16), MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [25] | "Large-scale proteomics analysis of the human kinome." Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G., Mann M., Daub H. Mol. Cell. Proteomics 8:1751-1764(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-208; SER-409; SER-456; SER-486 AND SER-722, PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-376 (ISOFORMS 13 AND 14), MASS SPECTROMETRY. |
| [26] | "Par1b/MARK2 phosphorylates kinesin-like motor protein GAKIN/KIF13B to regulate axon formation." Yoshimura Y., Terabayashi T., Miki H. Mol. Cell. Biol. 30:2206-2219(2010) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION IN PHOSPHORYLATION OF KIF13B. |
| [27] | "The tau of MARK: a polarized view of the cytoskeleton." Matenia D., Mandelkow E.M. Trends Biochem. Sci. 34:332-342(2009) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW. |
| [28] | "Structure and function of polarity-inducing kinase family MARK/Par-1 within the branch of AMPK/Snf1-related kinases." Marx A., Nugoor C., Panneerselvam S., Mandelkow E. FASEB J. 24:1637-1648(2010) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW. |
| [29] | "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis." Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Cervix carcinoma. |
| [30] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [31] | "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation." Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B. Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-40; SER-486 AND SER-619, MASS SPECTROMETRY. |
| [32] | "Helicobacter pylori CagA inhibits PAR1-MARK family kinases by mimicking host substrates." Nesic D., Miller M.C., Quinkert Z.T., Stein M., Chait B.T., Stebbins C.E. Nat. Struct. Mol. Biol. 17:130-132(2010) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 49-363 IN COMPLEX WITH H.PYLORI CAGA PEPTIDE INHIBITOR. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | X97630 mRNA. Translation: CAA66229.1. AB188493 mRNA. Translation: BAD37141.1. BT007342 mRNA. Translation: AAP36006.1. AP003780 Genomic DNA. No translation available. BC008771 mRNA. Translation: AAH08771.2. BC084540 mRNA. Translation: AAH84540.1. AF387638 mRNA. Translation: AAK82368.1. Different initiation. Z25427 mRNA. Translation: CAA80914.1. | ||||||||||||
| IPI | IPI00290158. IPI00335766. IPI00555696. IPI00555760. IPI00555838. IPI00556171. IPI00556187. IPI00556468. IPI00556593. IPI00556620. IPI00556650. IPI00718858. IPI00877119. IPI00939910. | ||||||||||||
| PIR | G01025. I38217. | ||||||||||||
| RefSeq | NP_001034558.2. NM_001039469.2. NP_001156768.1. NM_001163296.1. NP_001156769.1. NM_001163297.1. NP_004945.4. NM_004954.4. NP_059672.2. NM_017490.3. | ||||||||||||
| UniGene | Hs.567261. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | Q7KZI7. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| DIP | DIP-31321N. | ||||||||||||
| IntAct | Q7KZI7. 28 interactions. | ||||||||||||
| MINT | MINT-1149196. | ||||||||||||
| STRING | 9606.ENSP00000389184. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | Q7KZI7. | ||||||||||||
Polymorphism databases | |||||||||||||
| DMDM | 62510922. | ||||||||||||
Proteomic databases | |||||||||||||
| PaxDb | Q7KZI7. | ||||||||||||
| PRIDE | Q7KZI7. | ||||||||||||
Protocols and materials databases | |||||||||||||
| DNASU | 2011. | ||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000315032; ENSP00000326632; ENSG00000072518. ENST00000350490; ENSP00000294247; ENSG00000072518. ENST00000361128; ENSP00000355091; ENSG00000072518. ENST00000377809; ENSP00000367040; ENSG00000072518. ENST00000377810; ENSP00000367041; ENSG00000072518. ENST00000402010; ENSP00000385751; ENSG00000072518. ENST00000408948; ENSP00000386128; ENSG00000072518. ENST00000413835; ENSP00000389184; ENSG00000072518. ENST00000508192; ENSP00000425765; ENSG00000072518. ENST00000509502; ENSP00000423974; ENSG00000072518. ENST00000513765; ENSP00000421075; ENSG00000072518. | ||||||||||||
| GeneID | 2011. | ||||||||||||
| KEGG | hsa:2011. | ||||||||||||
| UCSC | uc001nxv.4. human. uc001nxw.3. human. uc001nxx.3. human. uc001nxz.4. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 2011. | ||||||||||||
| GeneCards | GC11P063606. | ||||||||||||
| HGNC | HGNC:3332. MARK2. | ||||||||||||
| HPA | HPA038790. | ||||||||||||
| MIM | 600526. gene. | ||||||||||||
| neXtProt | NX_Q7KZI7. | ||||||||||||
| PharmGKB | PA35047. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| eggNOG | COG0515. | ||||||||||||
| HOVERGEN | HBG052453. | ||||||||||||
| InParanoid | Q7KZI7. | ||||||||||||
| KO | K08798. | ||||||||||||
| OMA | QSELHER. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | Q7KZI7. | ||||||||||||
| Bgee | Q7KZI7. | ||||||||||||
| CleanEx | HS_MARK2. | ||||||||||||
| Genevestigator | Q7KZI7. | ||||||||||||
| GermOnline | ENSG00000072518. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| InterPro | IPR001772. KA1_dom. IPR011009. Kinase-like_dom. IPR000719. Prot_kinase_cat_dom. IPR017441. Protein_kinase_ATP_BS. IPR002290. Ser/Thr_dual-sp_kinase_dom. IPR008271. Ser/Thr_kinase_AS. IPR015940. UBA/transl_elong_EF1B_N_euk. [Graphical view] | ||||||||||||
| Pfam | PF02149. KA1. 1 hit. PF00069. Pkinase. 1 hit. [Graphical view] | ||||||||||||
| SMART | SM00220. S_TKc. 1 hit. SM00165. UBA. 1 hit. [Graphical view] | ||||||||||||
| SUPFAM | SSF103243. Kinase-assoc_KA1. 1 hit. SSF56112. Kinase_like. 1 hit. | ||||||||||||
| PROSITE | PS50032. KA1. 1 hit. PS00107. PROTEIN_KINASE_ATP. 1 hit. PS50011. PROTEIN_KINASE_DOM. 1 hit. PS00108. PROTEIN_KINASE_ST. 1 hit. PS50030. UBA. 1 hit. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other | |||||||||||||
| BindingDB | Q7KZI7. | ||||||||||||
| ChEMBL | CHEMBL3831. | ||||||||||||
| ChiTaRS | MARK2. human. | ||||||||||||
| EvolutionaryTrace | Q7KZI7. | ||||||||||||
| GenomeRNAi | 2011. | ||||||||||||
| NextBio | 8141. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | MARK2_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q7KZI7 Secondary accession number(s): Q15449 Q96RG0 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human and mouse protein kinases Human and mouse protein kinases: classification and index |
| Human chromosome 11 Human chromosome 11: entries, gene names and cross-references to MIM |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
